PEMGX
Price
$44.08
Change
-$0.06 (-0.14%)
Updated
Jan 22 closing price
Net Assets
29.78B
PRDMX
Price
$48.82
Change
+$0.31 (+0.64%)
Updated
Jan 22 closing price
Net Assets
2.96B
Ad is loading...

PEMGX vs PRDMX

Header iconPEMGX vs PRDMX Comparison
Open Charts PEMGX vs PRDMXBanner chart's image
Principal MidCap A
Price$44.08
Change-$0.06 (-0.14%)
VolumeN/A
Net Assets29.78B
T. Rowe Price Diversified Mid Cap Gr
Price$48.82
Change+$0.31 (+0.64%)
VolumeN/A
Net Assets2.96B
PEMGX vs PRDMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEMGX vs. PRDMX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEMGX is a Hold and PRDMX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 29.8B vs. PRDMX (2.96B). PEMGX (0.00) and PRDMX (0.00) have matching dividends . PEMGX was incepted earlier than PRDMX: PEMGX (20 years) vs PRDMX (21 years). PRDMX is a more actively managed with annual turnover of: 49.70 vs. PEMGX (10.10). PEMGX has a lower initial minimum investment than PRDMX: PEMGX (1000) vs PRDMX (2500). PRDMX annual gain was more profitable for investors over the last year : 21.23 vs. PEMGX (18.56). PEMGX return over 5 years is better than : 40.20 vs. PRDMX (29.15).
PEMGXPRDMXPEMGX / PRDMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years21 years-
Gain YTD3.4267.06149%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets29.8B2.96B1,007%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.5621.2387%
Returns for 3 years24.4122.17110%
Returns for 5 years40.2029.15138%
Returns for 10 years105.40108.6397%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WHG15.280.18
+1.19%
Westwood Holdings Group
LASR11.570.10
+0.87%
nLIGHT
PSEC4.38-0.01
-0.23%
Prospect Capital Corp
TCBP0.36N/A
-1.37%
TC BioPharm (Holdings) plc
PSN94.86-1.58
-1.64%
Parsons Corp